Sarepta refuses to pull gene therapy despite FDA order
Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the US Food and…
All articles by Abigail Beaney
Abigail Beaney
Abigail Beaney is the editor of Clinical Trials Arena. Abigail has expertise in clinical trial regulation, trial design, outsourcing, and cell and gene therapies. Abigail also has covered news and has a wealth of knowledge across several therapy areas including neurodegenerative, infectious and metabolic diseases. Abigail holds a first-class BA (Hons) degree in Journalism from the University of Central Lancashire in the United Kingdom. She has also obtained the National Qualification in Journalism through the UK's media industry body, the National Council for the Training of Journalists. Contact Abigail
-
-
GSK’s Blenrep faces setback as FDA cancer committee votes against approval
The US Food and Drug Administration’s (FDA’s) Oncologic Drugs Advisory Committee (ODAC) has voted against the benefit/risk profile of GSK’s Blenrep (belantamab…
-
PEPFAR funding protection offers “hope” for people living with HIV
The White House’s decision to safeguard $400m in President's Emergency Plan for AIDS Relief (PEPFAR) funding to support the global…
-
Trump’s 200% tariff threat could send shockwaves through pharma supply chains
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply…
-
Research warns of rising HIV cases in Africa amid global funding cuts
Global funding cuts, including those made by the Trump administration, are set to increase cases of human immunodeficiency virus (HIV)…
-
Protecting patients’ data is vital for NHS single health record system
Experts are emphasising that safeguarding patient data from corporations and cyberattacks is vital for the NHS to create a single…
-
EHDS regulation will depend on strong patient confidence
European residents must be fully informed to properly trust the incoming European Health Data Space (EHDS) regulation if it is…
-
FDA genAI reviews hinge on clarity of dossiers
Sponsors will need to ensure they are complying and submitting full, understandable dossiers if they are hoping to benefit from…
-
BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory…
-
NHS England chair suggests England can learn from European health schemes
With the 10-year Health Plan on the horizon, the NHS could learn some tricks from France, Germany and the Nordics.…